{"id":"https://openalex.org/W7204926052","doi":"https://doi.org/10.1080/19420862.2026.2722707","title":"Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens","display_name":"Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens","publication_year":2026,"publication_date":"2026-09-01","ids":{"openalex":"https://openalex.org/W7204926052","doi":"https://doi.org/10.1080/19420862.2026.2722707","pmid":"https://pubmed.ncbi.nlm.nih.gov/42680712","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13540217"},"language":"en","primary_location":{"id":"doi:10.1080/19420862.2026.2722707","doi":"https://doi.org/10.1080/19420862.2026.2722707","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2026.2722707","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2026.2722707?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2026.2722707?needAccess=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101569386","display_name":"Martin Hofmann","orcid":"https://orcid.org/0000-0002-8870-6512","observed_orcids":["https://orcid.org/0000-0002-8870-6512"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin Hofmann","raw_affiliation_strings":["CMC Biologics, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":"https://orcid.org/0000-0002-8870-6512","affiliations":[{"raw_affiliation_string":"CMC Biologics, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015123153","display_name":"Felix Unverdorben","orcid":"https://orcid.org/0000-0003-3418-2650","observed_orcids":["https://orcid.org/0000-0003-3418-2650"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Felix Unverdorben","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087064729","display_name":"M. Gabriele Pszolla","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"M. Gabriele Pszolla","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026044717","display_name":"Nadine Aschmoneit","orcid":"https://orcid.org/0000-0002-9385-9740","observed_orcids":["https://orcid.org/0000-0002-9385-9740"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Nadine Aschmoneit","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033225713","display_name":"Meike Hutt","orcid":"https://orcid.org/0000-0002-5696-2140","observed_orcids":["https://orcid.org/0000-0002-5696-2140"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Meike Hutt","raw_affiliation_strings":["Clinical Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076142198","display_name":"Timo Manz","orcid":"https://orcid.org/0000-0003-0062-2902","observed_orcids":["https://orcid.org/0000-0003-0062-2902"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Timo Manz","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088860072","display_name":"Heiko Schuster","orcid":"https://orcid.org/0009-0002-6446-9425","observed_orcids":["https://orcid.org/0009-0002-6446-9425"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Heiko Schuster","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046457418","display_name":"Jens L. Hukelmann","orcid":"https://orcid.org/0000-0001-8360-9062","observed_orcids":["https://orcid.org/0000-0001-8360-9062"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Jens Hukelmann","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076746491","display_name":"Andreas Acs","orcid":"https://orcid.org/0009-0008-3391-2539","observed_orcids":["https://orcid.org/0009-0008-3391-2539"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Acs","raw_affiliation_strings":["Clinical Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049395898","display_name":"Clara Tenkerian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Clara Tenkerian","raw_affiliation_strings":["Clinical Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089906093","display_name":"Sarah Missel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sarah Missel","raw_affiliation_strings":["Bispecifics Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bispecifics Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041306331","display_name":"Michael M\u00f8lh\u00f8j","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Michael M\u00f8lh\u00f8j","raw_affiliation_strings":["CMC Biologics, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CMC Biologics, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035624280","display_name":"Christoph U. Schr\u00e4der","orcid":"https://orcid.org/0000-0002-0461-3782","observed_orcids":["https://orcid.org/0000-0002-0461-3782"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Christoph Schr\u00e4der","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073053476","display_name":"Claudia Wagner","orcid":"https://orcid.org/0000-0002-7311-2236","observed_orcids":["https://orcid.org/0000-0002-7311-2236"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Claudia Wagner","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080611627","display_name":"Dominik Maurer","orcid":"https://orcid.org/0000-0001-5273-7192","observed_orcids":["https://orcid.org/0000-0001-5273-7192"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Dominik Maurer","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072725340","display_name":"Sebastian Bunk","orcid":"https://orcid.org/0000-0001-8381-1375","observed_orcids":["https://orcid.org/0000-0001-8381-1375"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Sebastian Bunk","raw_affiliation_strings":["Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Discovery Unit, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030980984","display_name":"Carsten Reinhardt","orcid":"https://orcid.org/0000-0003-2905-1920","observed_orcids":["https://orcid.org/0000-0003-2905-1920"]},"institutions":[{"id":"https://openalex.org/I4210138096","display_name":"Immatics Biotechnologies (Germany)","ror":"https://ror.org/04qw0nt96","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210138096"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Carsten Reinhardt","raw_affiliation_strings":["Bispecifics Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bispecifics Development, Immatics\u202fBiotechnologies GmbH, Tuebingen, Germany","institution_ids":["https://openalex.org/I4210138096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5030980984"],"corresponding_institution_ids":["https://openalex.org/I4210138096"],"apc_list":{"value":2915,"currency":"GBP","value_usd":3575},"apc_paid":{"value":2915,"currency":"GBP","value_usd":3575},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"18","issue":"1","first_page":"2722707","last_page":"2722707"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.43869999051094055,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.43869999051094055,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.21060000360012054,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.20170000195503235,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/t-cell-redirection","display_name":"T cell redirection","score":0.6380000114440918},{"id":"https://openalex.org/keywords/adoptive-immunotherapy","display_name":"adoptive immunotherapy","score":0.9359999895095825},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.8320000171661377},{"id":"https://openalex.org/keywords/plasma-half-life","display_name":"plasma half-life","score":0.7519999742507935}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7035999894142151},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.5809999704360962},{"id":"https://openalex.org/C19317047","wikidata":"https://www.wikidata.org/wiki/Q412037","display_name":"T-cell receptor","level":4,"score":0.46320000290870667},{"id":"https://openalex.org/C89429830","wikidata":"https://www.wikidata.org/wiki/Q735710","display_name":"Scaffold","level":2,"score":0.453000009059906},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4075999855995178},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.3310999870300293},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.3172000050544739},{"id":"https://openalex.org/C3020495827","wikidata":"https://www.wikidata.org/wiki/Q426141","display_name":"Bispecific antibody","level":4,"score":0.28619998693466187},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.2824999988079071},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.2797999978065491},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.2669999897480011},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.2669000029563904}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000951","descriptor_name":"Antigens, Neoplasm","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006680","descriptor_name":"HLA Antigens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D011948","descriptor_name":"Receptors, Antigen, T-Cell","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D013601","descriptor_name":"T-Lymphocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D016219","descriptor_name":"Immunotherapy, Adoptive","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018033","descriptor_name":"Antibodies, Bispecific","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1080/19420862.2026.2722707","doi":"https://doi.org/10.1080/19420862.2026.2722707","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2026.2722707","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2026.2722707?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13540217","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13540217/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13540217/pdf/KMAB_18_2722707.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"MAbs","raw_type":"Text"},{"id":"pmid:42680712","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42680712","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:d0d77a0bba2c43ae92c9cb5ea7bddbba","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/d0d77a0bba2c43ae92c9cb5ea7bddbba","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"mAbs, Vol 18, Iss 1 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1080/19420862.2026.2722707","doi":"https://doi.org/10.1080/19420862.2026.2722707","is_oa":true,"landing_page_url":"https://doi.org/10.1080/19420862.2026.2722707","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/19420862.2026.2722707?needAccess=true","source":{"id":"https://openalex.org/S169123381","display_name":"mAbs","issn_l":"1942-0862","issn":["1942-0862","1942-0870"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310315740","host_organization_name":"Landes Bioscience","host_organization_lineage":["https://openalex.org/P4310315740"],"host_organization_lineage_names":["Landes Bioscience"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"mAbs","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7204926052.pdf","grobid_xml":"https://content.openalex.org/works/W7204926052.grobid-xml"},"referenced_works_count":83,"referenced_works":["https://openalex.org/W1821172549","https://openalex.org/W1986752029","https://openalex.org/W1991644988","https://openalex.org/W1993191461","https://openalex.org/W1995352925","https://openalex.org/W2001483547","https://openalex.org/W2004772469","https://openalex.org/W2014275356","https://openalex.org/W2015326650","https://openalex.org/W2015956932","https://openalex.org/W2020634797","https://openalex.org/W2023121198","https://openalex.org/W2039206013","https://openalex.org/W2068872497","https://openalex.org/W2078607441","https://openalex.org/W2080086146","https://openalex.org/W2083494119","https://openalex.org/W2093966230","https://openalex.org/W2106582884","https://openalex.org/W2111742915","https://openalex.org/W2120339346","https://openalex.org/W2134121541","https://openalex.org/W2136673346","https://openalex.org/W2138859976","https://openalex.org/W2213204442","https://openalex.org/W2270152626","https://openalex.org/W2291299225","https://openalex.org/W2379702652","https://openalex.org/W2464113003","https://openalex.org/W2481619050","https://openalex.org/W2571138221","https://openalex.org/W2591709377","https://openalex.org/W2703268623","https://openalex.org/W2733984019","https://openalex.org/W2747396160","https://openalex.org/W2767440408","https://openalex.org/W2783911823","https://openalex.org/W2793614926","https://openalex.org/W2794055210","https://openalex.org/W2795019963","https://openalex.org/W2809759411","https://openalex.org/W2897958605","https://openalex.org/W2903981326","https://openalex.org/W2904572271","https://openalex.org/W2914635378","https://openalex.org/W2953065444","https://openalex.org/W2979733442","https://openalex.org/W2987711192","https://openalex.org/W3005234850","https://openalex.org/W3006446512","https://openalex.org/W3011428345","https://openalex.org/W3015996050","https://openalex.org/W3016313554","https://openalex.org/W3017309521","https://openalex.org/W3045946240","https://openalex.org/W3105254545","https://openalex.org/W3127104862","https://openalex.org/W3134794297","https://openalex.org/W3171842402","https://openalex.org/W3177547893","https://openalex.org/W3181390667","https://openalex.org/W3196945974","https://openalex.org/W3200574709","https://openalex.org/W4200392753","https://openalex.org/W4220667214","https://openalex.org/W4224225059","https://openalex.org/W4285404371","https://openalex.org/W4292004444","https://openalex.org/W4308394690","https://openalex.org/W4321597246","https://openalex.org/W4378978693","https://openalex.org/W4379598720","https://openalex.org/W4382361627","https://openalex.org/W4385839624","https://openalex.org/W4387798677","https://openalex.org/W4388425206","https://openalex.org/W4391231786","https://openalex.org/W4402303553","https://openalex.org/W4402620887","https://openalex.org/W4403410375","https://openalex.org/W4410889835","https://openalex.org/W4415444739","https://openalex.org/W7162937651"],"related_works":["https://openalex.org/W4308394690","https://openalex.org/W4307165852","https://openalex.org/W3017309521","https://openalex.org/W4311099232","https://openalex.org/W4409625008","https://openalex.org/W4306728773","https://openalex.org/W2794362897","https://openalex.org/W7125413158","https://openalex.org/W7160497034","https://openalex.org/W4387972659"],"abstract_inverted_index":{"Redirection":[0],"of":[1,10,60,74,90,114,124],"T":[2],"lymphocytes":[3],"toward":[4],"cancer":[5],"cells":[6],"has":[7,42,64,97],"been":[8,43,65],"one":[9],"the":[11,20,72,82,111],"most":[12],"promising":[13],"treatment":[14],"concepts":[15],"in":[16,46,78,103,131,146],"oncology":[17,147],"developed":[18],"over":[19],"past":[21],"years":[22],"and":[23,35,93,120,137,148],"leading":[24],"to":[25,70,85],"multiple":[26],"regulatory":[27],"approvals":[28],"for":[29,140],"both":[30],"adoptive":[31],"cell":[32],"therapy":[33],"(ACT)":[34],"T-cell-engaging":[36],"bispecific":[37],"(TEB)":[38],"molecules.":[39],"However,":[40],"progress":[41],"achieved":[44],"predominantly":[45],"hematological":[47],"indications":[48],"by":[49],"aiming":[50],"at":[51],"so-called":[52],"lineage":[53],"antigens":[54,62,77,96],"(i.e.":[55],"CD19,":[56],"CD20,":[57],"BCMA).":[58],"Targeting":[59],"peptide-HLA":[61],"(pHLA)":[63],"proposed":[66],"as":[67],"a":[68,104,118,141],"strategy":[69],"overcome":[71],"paucity":[73],"suitable":[75],"surface":[76],"solid":[79],"cancers,":[80],"yet":[81],"technical":[83],"hurdle":[84],"specifically":[86],"address":[87],"this":[88],"class":[89,123],"low":[91],"copy":[92],"highly":[94,121],"promiscuous":[95],"so":[98],"far":[99],"hampered":[100],"its":[101],"use":[102,143],"broader":[105],"patient":[106],"population.":[107],"We":[108],"here":[109],"describe":[110],"successful":[112],"development":[113],"TCER":[115],"(T-Cell-Engaging":[116],"Receptor),":[117],"novel":[119],"versatile":[122],"T-cell":[125],"receptor":[126],"(TCR)-based":[127],"TEB":[128],"with":[129],"optimized":[130],"vivo":[132],"efficacy,":[133],"tolerability,":[134],"plasma":[135],"half-life,":[136],"stability":[138],"characteristics":[139],"broad":[142],"targeting":[144],"pHLA":[145],"beyond.":[149]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2026-09-02T00:00:00"}